List of Contents

Medical Plastic Compounds Market Size, Share, and Trends 2024 to 2034

The global medical plastic compounds market size was USD 73.66 billion in 2023, estimated at USD 78.23 billion in 2024 and is anticipated to reach around USD 140.98 billion by 2034, expanding at a CAGR of 6.07% from 2024 to 2034.

  • Last Updated : September 2024
  • Report Code : 1155
  • Category : Chemical and Material

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Medical Plastic Compounds Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Medical Plastic Compounds Market

5.1. Covid-19: Medical Plastic Compounds Industry Impact
5.2. Medical Plastic Compounds Business Impact Assessment: Covid-19
5.2.1. Supply Chain Challenges/Disruption
5.2.2. Market Trends and Medical Plastic Compounds Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Medical Plastic Compounds Manufacturers to deal with Covid-19 Pandemic Scenario

Chapter 6. Medical Plastic Compounds Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Increasing Prevalence of Chronic Disease
6.1.1.2. Rising Consumption of Polymers in Healthcare Industry
6.1.2. Market Restraints
6.1.2.1. Volatile Prices of Raw Materials
6.1.3. Market Opportunities
6.1.3.1. Increasing Research Activities to Develop Advanced Medical Grade Plastics
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition

Chapter 7. Global Medical Plastic Compounds Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Medical Plastic Compounds Market Revenue by Manufacturer
7.1.1.2. Medical Plastic Compounds Market Revenue Market Share by Manufacturer
7.1.1.3. Medical Plastic Compounds Market Production by Manufacturer
7.1.1.4. Medical Plastic Compounds Market Production Market Share by Manufacturer
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Capacity Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Manufacturers Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers

Chapter 8. Global Medical Plastic Compounds Market, By Product

8.1. Medical Plastic Compounds Market, by Product, 2024-2034
8.1.1. Polyethylene
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.1.2. Market Production and Forecast (2021-2034)
8.1.2. Polyvinylchloride
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.2.2. Market Production and Forecast (2021-2034)
8.1.3. Polypropylene
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.3.2. Market Production and Forecast (2021-2034)
8.1.4. Polyester
8.1.4.1. Market Revenue and Forecast (2021-2034)
8.1.4.2. Market Production and Forecast (2021-2034)
8.1.5. Polystyrene
8.1.5.1. Market Revenue and Forecast (2021-2034)
8.1.5.2. Market Production and Forecast (2021-2034)
8.1.6. Polycarbonate
8.1.6.1. Market Revenue and Forecast (2021-2034)
8.1.6.2. Market Production and Forecast (2021-2034)
8.1.7. Acrylics
8.1.7.1. Market Revenue and Forecast (2021-2034)
8.1.7.2. Market Production and Forecast (2021-2034)
8.1.8. Polyurethane
8.1.8.1. Market Revenue and Forecast (2021-2034)
8.1.8.2. Market Production and Forecast (2021-2034)
8.1.9. Others
8.1.9.1. Market Revenue and Forecast (2021-2034)
8.1.9.2. Market Production and Forecast (2021-2034)

Chapter 9. Global Medical Plastic Compounds Market, By Application

9.1. Medical Plastic Compounds Market, by Application, 2024-2034
9.1.1. Catheters
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.1.2. Market Consumption and Forecast (2021-2034)
9.1.2. Disposables
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.2.2. Market Consumption and Forecast (2021-2034)
9.1.3. Drug Delivery System
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.3.2. Market Consumption and Forecast (2021-2034)
9.1.4. Surgical Instruments
9.1.4.1. Market Revenue and Forecast (2021-2034)
9.1.4.2. Market Consumption and Forecast (2021-2034)
9.1.5. Implants
9.1.5.1. Market Revenue and Forecast (2021-2034)
9.1.5.2. Market Consumption and Forecast (2021-2034)
9.1.6. Medical Bags
9.1.6.1. Market Revenue and Forecast (2021-2034)
9.1.6.2. Market Consumption and Forecast (2021-2034)
9.1.7. Others
9.1.7.1. Market Revenue and Forecast (2021-2034)
9.1.7.2. Market Consumption and Forecast (2021-2034)

Chapter 10. Global Medical Plastic Compounds Market, Regional Estimates and Trend Forecast

10.1. North America
10.1.1. Market Revenue and Production Forecast by Product (2021-2034)
10.1.2. Market Revenue and Consumption Forecast by Application (2021-2034)
10.1.3. U.S
10.1.3.1. Market Revenue and Production Forecast (2021-2034)
10.1.3.2. Market Revenue and Consumption Forecast (2021-2034)
10.1.4. Canada
10.1.4.1. Market Revenue and Production Forecast (2021-2034)
10.1.4.2. Market Revenue and Consumption Forecast (2021-2034)
10.2. Europe
10.2.1. Market Revenue and Production Forecast by Product (2021-2034)
10.2.2. Market Revenue and Consumption Forecast by Application (2021-2034)
10.2.3. UK
10.2.3.1. Market Revenue and Production Forecast (2021-2034)
10.2.3.2. Market Revenue and Consumption Forecast (2021-2034)
10.2.4. Germany
10.2.4.1. Market Revenue and Production Forecast (2021-2034)
10.2.4.2. Market Revenue and Consumption Forecast (2021-2034)
10.2.5. France
10.2.5.1. Market Revenue and Production Forecast (2021-2034)
10.2.5.2. Market Revenue and Consumption Forecast (2021-2034)
10.2.6. Rest of EU
10.2.6.1. Market Revenue and Production Forecast (2021-2034)
10.2.6.2. Market Revenue and Consumption Forecast (2021-2034)
10.3. Asia Pacific (APAC)
10.3.1. Market Revenue and Production Forecast by Product (2021-2034)
10.3.2. Market Revenue and Consumption Forecast by Application (2021-2034)
10.3.3. China
10.3.3.1. Market Revenue and Production Forecast (2021-2034)
10.3.3.2. Market Revenue and Consumption Forecast (2021-2034)
10.3.4. India
10.3.4.1. Market Revenue and Production Forecast (2021-2034)
10.3.4.2. Market Revenue and Consumption Forecast (2021-2034)
10.3.5. Japan
10.3.5.1. Market Revenue and Production Forecast (2021-2034)
10.3.5.2. Market Revenue and Consumption Forecast (2021-2034)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Production Forecast (2021-2034)
10.3.6.2. Market Revenue and Consumption Forecast (2021-2034)
10.4. LATAM
10.4.1. Market Revenue and Production Forecast by Product (2021-2034)
10.4.2. Market Revenue and Consumption Forecast by Application (2021-2034)
10.4.3. Brazil
10.4.3.1. Market Revenue and Production Forecast (2021-2034)
10.4.3.2. Market Revenue and Consumption Forecast (2021-2034)
10.4.4. Rest of LATAM
10.4.4.1. Market Revenue and Production Forecast (2021-2034)
10.4.4.2. Market Revenue and Consumption Forecast (2021-2034)
10.5. Middle East and Africa (MEA)
10.5.1. Market Revenue and Production Forecast by Product (2021-2034)
10.5.2. Market Revenue and Consumption Forecast by Application (2021-2034)
10.5.3. GCC
10.5.3.1. Market Revenue and Production Forecast (2021-2034)
10.5.3.2. Market Revenue and Consumption Forecast (2021-2034)
10.5.4. North Africa
10.5.4.1. Market Revenue and Production Forecast (2021-2034)
10.5.4.2. Market Revenue and Consumption Forecast (2021-2034)
10.5.5. South Africa
10.5.5.1. Market Revenue and Production Forecast (2021-2034)
10.5.5.2. Market Revenue and Consumption Forecast (2021-2034)
10.5.6. Rest of MEA
10.5.6.1. Market Revenue and Production Forecast (2021-2034)
10.5.6.2. Market Revenue and Consumption Forecast (2021-2034)

Chapter 11. Company Profiles

11.1. Nolato AB
11.1.1. Company Overview, Business Information, Regional Presence
11.1.2. Product Portfolio Analysis
11.1.2.1. Product Details, Specification, Application
11.1.3. Revenue, Production Capacity, Price, and Gross Margin
11.1.4. Recent Developments and Strategies
11.2. Freudenberg Medical LLC
11.2.1. Company Overview, Business Information, Regional Presence
11.2.2. Product Portfolio Analysis
11.2.2.1. Product Details, Specification, Application
11.2.3. Revenue, Production Capacity, Price, and Gross Margin
11.2.4. Recent Developments and Strategies
11.3. Rochling Group
11.3.1. Company Overview, Business Information, Regional Presence
11.3.2. Product Portfolio Analysis
11.3.2.1. Product Details, Specification, Application
11.3.3. Revenue, Production Capacity, Price, and Gross Margin
11.3.4. Recent Developments and Strategies
11.4. GW Plastics Inc.
11.4.1. Company Overview, Business Information, Regional Presence
11.4.2. Product Portfolio Analysis
11.4.2.1. Product Details, Specification, Application
11.4.3. Revenue, Production Capacity, Price, and Gross Margin
11.4.4. Recent Developments and Strategies
11.5. MedPlast Inc.
11.5.1. Company Overview, Business Information, Regional Presence
11.5.2. Product Portfolio Analysis
11.5.2.1. Product Details, Specification, Application
11.5.3. Revenue, Production Capacity, Price, and Gross Margin
11.5.4. Recent Developments and Strategies
11.6. Phillips Medisisze Corporation
11.6.1. Company Overview, Business Information, Regional Presence
11.6.2. Product Portfolio Analysis
11.6.2.1. Product Details, Specification, Application
11.6.3. Revenue, Production Capacity, Price, and Gross Margin
11.6.4. Recent Developments and Strategies
11.7. C&J Industries Inc.
11.7.1. Company Overview, Business Information, Regional Presence
11.7.2. Product Portfolio Analysis
11.7.2.1. Product Details, Specification, Application
11.7.3. Revenue, Production Capacity, Price, and Gross Margin
11.7.4. Recent Developments and Strategies
11.8. Tekni-Plex, Inc.
11.8.1. Company Overview, Business Information, Regional Presence
11.8.2. Product Portfolio Analysis
11.8.2.1. Product Details, Specification, Application
11.8.3. Revenue, Production Capacity, Price, and Gross Margin
11.8.4. Recent Developments and Strategies
11.9. Pexco LLC
11.9.1. Company Overview, Business Information, Regional Presence
11.9.2. Product Portfolio Analysis
11.9.2.1. Product Details, Specification, Application
11.9.3. Revenue, Production Capacity, Price, and Gross Margin
11.9.4. Recent Developments and Strategies
11.10. Medical Plastic Devices Inc.
11.10.1. Company Overview, Business Information, Regional Presence
11.10.2. Product Portfolio Analysis
11.10.2.1. Product Details, Specification, Application
11.10.3. Revenue, Production Capacity, Price, and Gross Margin
11.10.4. Recent Developments and Strategies

Chapter 12. Appendix

12.1. About Us
12.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client